TNXP — Tonix Pharmaceuticals Holding Corp.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1430306 ·
Last close
$2.94
Market Cap
$57.13M
52W High
$20.56
52W Low
$2.81
ADV30
1,099,390
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 17,234,000 | 15,982,000 | -54,766,000 | -53,329,000 | 242,426,000 | 162,793,000 | 42,941,000 |
| Jun 2026 | 13,544,000 | 12,841,000 | -41,935,000 | -40,552,000 | 254,088,000 | 176,232,000 | 31,807,000 |
| Mar 2026 | 6,878,000 | 5,300,000 | -41,537,000 | -40,194,000 | 257,912,000 | 185,470,000 | 30,775,000 |
| Dec 2025 | 5,390,000 | 4,332,000 | -48,215,000 | -46,910,000 | 277,171,000 | 207,637,000 | 32,021,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-165,285,000
Investing CF
$-3,903,000
Financing CF
$141,136,000
CapEx
$-4,756,000
Dividends Paid
—
Buybacks
$-7,811,000
EPS Diluted TTM
$-12.24
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-935,461,000
Inventory
$5,678,000
Receivables
$15,314,000
ST Investments
—
EBIT TTM
$-162,392,000
Pretax Income TTM
$-159,666,000
Interest Exp TTM
$0
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$43,046,000
EBITDA
$-185,484,992
Free Cash Flow
$-102,010,376
Enterprise Value
$-103,051,136
Total Cash
$162,792,992
Total Debt
$1,253,000
Shares Out
19,431,516
Trailing EPS
$-12.39
Book Value
$10.42
ROE
-84.1%
ROA
-47.4%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 13,107,000 | -122,691,000 | -124,021,000 | 277,171,000 | 32,021,000 | 245,150,000 | -99,844,000 |
| Dec 2024 | 10,094,000 | -75,150,000 | -130,036,000 | 162,890,000 | 23,332,000 | 139,558,000 | -60,925,000 |
| Dec 2023 | 7,768,000 | -118,380,000 | -116,658,000 | 154,457,000 | 48,932,000 | 105,525,000 | -102,003,000 |
| Dec 2022 | 0 | -112,091,000 | -110,218,000 | 225,690,000 | 18,508,000 | 207,182,000 | -98,053,000 |
TTM Snapshot
Revenues TTM
$29,102,000
NetIncome TTM
$-159,666,000
OpCashFlow TTM
—
Assets (Latest)
$254,088,000
Forward EPS
$-7.00
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $2.82 · call volume: 125 · put volume: 20
Expected Move to 2026-12-18:
±$1.35
(47.87%) —
implied range
$1.47 –
$4.17
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BOLD | Boundless Bio, Inc. | $56.90M | $2.41 | — |
| CTOR | CITIUS ONCOLOGY, INC. | $57.91M | $0.55 | — |
| QUCY | Quantum Cyber N.V. | $54.38M | $0.62 | — |
| XBIT | XBiotech Inc. | $54.27M | $1.78 | — |
| INCR | Intercure Ltd. | $54.16M | $3.61 | — |
News headlines (Yahoo Finance, 1h cache)
TNXP: Tonmya® Launch Continues to Build Momentum; 37% QoQ Growth in Revenue
2026-11-16 10:24 · Yahoo
Tonix Pharmaceuticals (TNXP) Stock Fair Value Falls As Analysts Weigh Tonmya And Funding Risk
2026-11-12 08:11 · Yahoo
Tonix Pharmaceuticals’ TONMYA Sales Jump 37% as Insurance Coverage Expands
2026-11-11 03:14 · Yahoo
Tonix Pharmaceuticals (TNXP) Q3 2026 Earnings Call Transcript
2026-11-09 21:44 · Yahoo
Tonix Pharmaceuticals Holding Corp (TNXP) Q3 2026 Earnings Call Highlights: Tonmya Sales Surge ...
2026-11-09 21:06 · Yahoo
What Tonix Pharmaceuticals (TNXP) Said on Its Q3 Earnings Call
2026-11-09 18:14 · Yahoo
Tonix Pharmaceuticals Reports Third Quarter 2026 Financial Results and Operational Highlights
2026-11-09 12:00 · Yahoo
Tonix Pharmaceuticals to Present at Guggenheim’s 3rd Annual Healthcare Innovation Conference
2026-11-04 12:00 · Yahoo
Tonix Pharmaceuticals Appoints George Lederman, Ph.D., as Executive Vice President of Strategy and Transformation
2026-11-02 12:00 · Yahoo
Tonix Pharmaceuticals Presented an Analysis of Phase 3 Data Demonstrating TONMYA® Improved Physical Symptoms and Functional Ability of Patients with Fibromyalgia at the IASP 2026 World Congress on Pai
2026-10-27 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.